Summary:
In this podcast, recorded at the 2024 Immuno-Oncology 360º Summit, Dr Margaret Callahan, University of Connecticut, goes over the history of tumor vaccines in immuno-oncology, particularly the lessons learned as to what has worked, what has not, and why.
Dr Callahan also speaks to the current class of RNA vaccines, particularly how they may address previous hurdles, what we are gaining from the deeper understanding of neoantigens, and proving the safety and feasibility of RNA as a platform.
For more information, go to immuno-oncology360.org
